Connor, Clark & Lunn Investment Management Ltd. - PMV PHARMACEUTICALS INC ownership

PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 116 filers reported holding PMV PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.9%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of PMV PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,041,952
+1.5%
169,699
+3.5%
0.01%0.0%
Q2 2023$1,026,402
+37.9%
163,962
+5.1%
0.01%
+25.0%
Q1 2023$744,397
-26.0%
156,058
+34.9%
0.00%
-33.3%
Q4 2022$1,006,494115,6890.01%
Other shareholders
PMV PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 3,234,911$74,726,00044.17%
Euclidean Capital LLC 2,336,909$53,983,00030.69%
OUP Management Co., LLC 989,232$22,851,00010.30%
Nextech Invest Ltd. 1,385,807$32,012,0008.43%
Boxer Capital, LLC 2,838,236$65,563,0002.55%
PERSONAL CFO SOLUTIONS, LLC 550,342$12,713,0002.38%
Orbimed Advisors 7,330,423$169,333,0002.18%
Asymmetry Capital Management, L.P. 97,680$2,256,0001.20%
RTW INVESTMENTS, LP 2,980,960$68,860,0001.01%
HighVista Strategies LLC 39,777$919,0000.73%
View complete list of PMV PHARMACEUTICALS INC shareholders